These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 9758530

  • 1. USAN Council. List No.407. New names. Lenercept.
    Clin Pharmacol Ther; 1998 Aug; 64(2):234. PubMed ID: 9758530
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. TNF-alpha-targeted therapy in rheumatoid arthritis.
    Wendling D, Toussirot E.
    Rev Rhum Engl Ed; 1999 Apr; 66(4):187-91. PubMed ID: 10339773
    [No Abstract] [Full Text] [Related]

  • 4. TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.
    Neurology; 1999 Aug 11; 53(3):457-65. PubMed ID: 10449104
    [Abstract] [Full Text] [Related]

  • 5. Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein, Ro 45-2081 (lenercept): results of a dose-finding study in rheumatoid arthritis.
    Furst DE, Weisman M, Paulus HE, Bulpitt K, Weinblatt M, Polisson R, Zaug M, Kneer J, Van der Auwera P, Stevens RM.
    J Rheumatol; 2003 Oct 11; 30(10):2123-6. PubMed ID: 14528504
    [Abstract] [Full Text] [Related]

  • 6. Anti-inflammatory response after infusion of p55 soluble tumor necrosis factor receptor fusion protein for severe sepsis.
    Butty VL, Roux-Lombard P, Garbino J, Dayer JM, Ricou B, Geneva Sepsis Network.
    Eur Cytokine Netw; 2003 Oct 11; 14(1):15-9. PubMed ID: 12799209
    [Abstract] [Full Text] [Related]

  • 7. Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients.
    Abraham E, Laterre PF, Garbino J, Pingleton S, Butler T, Dugernier T, Margolis B, Kudsk K, Zimmerli W, Anderson P, Reynaert M, Lew D, Lesslauer W, Passe S, Cooper P, Burdeska A, Modi M, Leighton A, Salgo M, Van der Auwera P, Lenercept Study Group.
    Crit Care Med; 2001 Mar 11; 29(3):503-10. PubMed ID: 11373411
    [Abstract] [Full Text] [Related]

  • 8. Animal pharmacokinetics of the tumor necrosis factor receptor-immunoglobulin fusion protein lenercept and their extrapolation to humans.
    Richter WF, Gallati H, Schiller CD.
    Drug Metab Dispos; 1999 Jan 11; 27(1):21-5. PubMed ID: 9884305
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Isolated digital vasculitis in a patient with rheumatoid arthritis: good response to tumour necrosis factor alpha blocking treatment.
    den Broeder AA, van den Hoogen FH, van de Putte LB.
    Ann Rheum Dis; 2001 May 11; 60(5):538-9. PubMed ID: 11302883
    [Abstract] [Full Text] [Related]

  • 12. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
    Corcoran AE, Scallon BJ, Trinh H, Chernajovsky Y, Ghrayeb J, Feldmann M.
    Eur Cytokine Netw; 1998 Sep 11; 9(3):255-62. PubMed ID: 9831174
    [Abstract] [Full Text] [Related]

  • 13. Taiwan experience with etanercept in juvenile rheumatoid arthritis.
    Lai JH.
    J Microbiol Immunol Infect; 2005 Dec 11; 38(6):451-4. PubMed ID: 16341348
    [No Abstract] [Full Text] [Related]

  • 14. National Meeting of the American College of Rheumatology. November 8-12, 1998, San Diego, California.
    Badii M.
    Clin Invest Med; 1999 Apr 11; 22(2):63-4. PubMed ID: 10340106
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of rheumatoid arthritis with a tumor necrosis factor receptor-Fc fusion protein.
    Epstein WV.
    N Engl J Med; 1997 Nov 20; 337(21):1559-60; author reply 1560-1. PubMed ID: 9380130
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of tumor necrosis factor alpha and ankylosing spondylitis.
    Marzo-Ortega H, Emery P, McGonagle D.
    N Engl J Med; 2003 Jan 23; 348(4):359-61; author reply 359-61. PubMed ID: 12542065
    [No Abstract] [Full Text] [Related]

  • 18. [Anti-TNF-alpha-treatment of arthritis--4-year follow-up].
    Petri A, Dreyer L, Danneskiold-Samsøe B, Terslev L, Bliddal H.
    Ugeskr Laeger; 2003 Nov 24; 165(48):4649-52. PubMed ID: 14677465
    [No Abstract] [Full Text] [Related]

  • 19. Inhibitors of tumor necrosis factor for rheumatoid arthritis.
    Moreland LW.
    J Rheumatol Suppl; 1999 May 24; 57():7-15. PubMed ID: 10328137
    [Abstract] [Full Text] [Related]

  • 20. The role of tumor necrosis factor inhibitors in patients with RA.
    Trethewey P.
    JAAPA; 2002 Sep 24; 15(9):23-4, 27, 30 passim. PubMed ID: 12395668
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.